Download App

Log in to access Online Inquiry
Company Overview More
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
CEO: Crystal M.D., Roger
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

OPNT Opiant Pharmaceuticals

13.710-0.300-2.14%
Close 05/23 17:26 ET
High
14.000
Open
14.000
Turnover
333.00K
Low
13.290
Pre Close
14.010
Volume
24.39K
Market Cap
69.74M
P/E(TTM)
Loss
52wk High
37.711
Shares
5.09M
P/E(Static)
26.88
52wk Low
7.340
Float Cap
64.76M
Bid/Ask %
0.00%
Historical High
48.000
Shs Float
4.72M
Volume Ratio
0.32
Historical Low
6.788
Dividend TTM
--
Div Yield TTM
10
P/B
1.78
Dividend LFY
--
Div Yield LFY
72.94%
Turnover Ratio
0.52%
Amplitude
5.07%
Avg Price
13.653
Lot Size
1
Float Cap
64.76M
Bid/Ask %
0.00%
Historical High
48.000
Shs Float
4.72M
Volume Ratio
0.32
Historical Low
6.788
Dividend TTM
--
P/B
1.78
Dividend LFY
--
Turnover Ratio
0.52%
Amplitude
5.07%
Avg Price
13.653
Lot Size
1
Price Forecast

No Data

News

Comment